CTLA4 and cancer: Programmed cell death protein 1 (PD-1)/PD-L1 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) are inhibitory checkpoint receptors that suppress T cell activation, affecting the immune response against cancer.